Interesting appointments and i guess somewhat as was expected. Not quite sure if she is the most desired person for the role ? Gold to energy to biotech ? But we shall soon see.
Dr Hayes is a good or atleast very interesting appointment as he was at Janssen and looking over the previous deal before 3 years st Amgen so obviously has a keen interest. It never hurts to get heavy hitters from big pharma take the top spots but also not the first time. PYC has had a pretty impressive record of pulling plenty of big pharma ex VP's to the board over the years excited at what may be Boehringer Ingeleim, Bristol-Myers Squibb, Schering, Pfizer etc just need to deliver what they've all taken those positions looking for.
New CEO and CSO, page-11
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.3¢ |
Change
-0.008(5.77%) |
Mkt cap ! $571.5M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.0¢ | 12.3¢ | $129.6K | 1.035M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 1436718 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 317395 | 14 |
View Market Depth
| Last trade - 14.36pm 16/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |